A cancer therapy based on fusing two types of cells into a single unit shows promise in strengthening existing treatments for acute myeloid leukemia. The approach joins blood platelets that carry cancer drugs with stem cells that guide the platelets into bone marrow where leukemia begins. Researchers found that when injected into mice that had… Read more

“This is when I start feeling my age,” says Anne Corcoran. She’s a scientist at the Babraham Institute, a human biology research centre in Cambridge, UK. Corcoran leads a group that looks at how our genomes – the DNA coiled in almost every cell in our bodies – relate to our immune systems, and specifically… Read more

Leukemia undercuts the ability of normal cells to consume glucose, thus leaving more glucose available to feed its own growth, a University of Colorado Cancer Center study reports. Cancer needs energy to drive its out-of-control growth. It gets energy in the form of glucose, in fact consuming so much glucose that one method for imaging… Read more

A new type of anti-cancer drug that can put cancer cells into a permanent sleep, without the harmful side-effects caused by conventional cancer therapies, has been discovered by scientists. The research reveals the first class of anti-cancer drugs that work by putting the cancer cell to sleep – arresting tumour growth and spread without damaging… Read more

Chemotherapy for acute myeloid leukemia could be improved by giving patients a drug currently used to treat an unrelated condition, researchers led by a team from Imperial College London have found. Acute myeloid leukaemia (AML) is an aggressive cancer that stops healthy blood cell production. Chemotherapy is the standard treatment, but improvements are needed as… Read more